Intensive glucose regulation does not reduce enzymatic infarct size in hyperglycemic acute coronary syndromes: results of the randomized BIOMArCS-2 glucose trial | Zendy

AI Assistant Blog Pricing

Intensive glucose regulation does not reduce enzymatic infarct size in hyperglycemic acute coronary syndromes: results of the randomized BIOMArCS-2 glucose trial

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.